The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Cytokine-mediated hypersensitivity reactions to carboplatin in early triple-negative breast cancer with neoadjuvant pembrolizumab plus chemotherapy.
 
Masahiro Kuno
No Relationships to Disclose
 
Yosuke Aoyama
Honoraria - Lilly; MSD
 
Rika Kizawa
No Relationships to Disclose
 
Yukinori Ozaki
Honoraria - Chugai Pharma; Daiichi Sankyo; Kyowa Kirin International; Lilly; Pfizer
 
Jun Masuda
Honoraria - Chugai Pharma; Kyowa Kirin; Nippon Kayaku
Consulting or Advisory Role - SB TEMPUS Corp.
 
Mami Kurata
No Relationships to Disclose
 
Yuri Kimura
No Relationships to Disclose
 
Tetsuyo Maeda
No Relationships to Disclose
 
Meiko Nishimura
No Relationships to Disclose
 
Kazuyo Yoshida
No Relationships to Disclose
 
Mari Hosonaga
No Relationships to Disclose
 
Nami Yamashita
No Relationships to Disclose
 
Ippei Fukada
No Relationships to Disclose
 
Takayuki Kobayashi
No Relationships to Disclose
 
Toshimi Takano
Honoraria - Daiichi Sankyo; Lilly
 
Takayuki Ueno
Honoraria - AstraZeneca Japan; Chugai Pharma; Eisai; Novartis
Research Funding - Lilly Japan (Inst)